Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy. This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This abstract does ...
Phase II Trial of Docetaxel, Cisplatin, Fluorouracil, and Leucovorin as Induction for Squamous Cell Carcinoma of the Head and Neck PURPOSE: Stealth (ALZA Corporation, Palo Alto, CA) liposomal drug ...
Dr. Liam Spillane shares breakthroughs in cryo-EM spectroscopy, emphasizing dose-fractionated EELS and direct detection technologies for superior data quality.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback